SKYSTAR BIO-PHARMA CO's ticker is SKBI and the CUSIP is 830884300. A total of 11 filers reported holding SKYSTAR BIO-PHARMA CO in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rotella Capital Management, Inc. | 33,393 | $140,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 289,110 | $1,211,000 | 0.05% |
| Spark Investment Management LLC | 21,400 | $89,000 | 0.01% |
| ClariVest Asset Management LLC | 19,720 | $82,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 24,300 | $102,000 | 0.00% |
| EAGLE GLOBAL ADVISORS LLC | 22,576 | $95,000 | 0.00% |
| Renaissance Technologies | 14,600 | $61,000 | 0.00% |
| MORGAN STANLEY | 8,514 | $36,000 | 0.00% |
| BlackRock Institutional Trust Company, N.A. | 175,808 | $737,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 15,900 | $67,000 | 0.00% |